Effect of cA2 Anti–Tumor Necrosis Factor-α Antibody Therapy on Hematopoiesis of Patients with Myelodysplastic SyndromesAnna Boula, Helen Α. Papadaki, Maria Psyllaki et al.|Clinical Cancer Research|2006Cited by 27
P-43 Effect of the treatment withCA2 anti-TNF monoclonal antibody on the bone marrow (BM) progenitor cell reserve and function and stromal cell function in patients with myelodysplastic syndrome (MDS). A study of the Greek mds study groupHelen Α. Papadaki, George D. Eliopoulos, Michalis Voulgarelis et al.|Leukemia Research|2005Cited by 0